Abstract:Objective: To investigate the utility of ultrafast dynamic-contrast-enhanced (DCE) MRI in visualization and quantitative characterization of pregnancy-associated breast cancer (PABC) and its differentiation from background-parenchymal-enhancement (BPE) among lactating patients. Materials and methods: Twenty-nine lactating participants, including 10 PABC patients and 19 healthy controls, were scanned on 3-T MRI using a conventional DCE protocol interleaved with a golden-angle radial sparse parallel (GRASP) ultrafast sequence for the initial phase. The timing of the visualization of PABC lesions was compared to lactational BPE. Contrast-noise ratio (CNR) was compared between the ultrafast and conventional DCE sequences. The differences in each group's ultrafast-derived kinetic parameters including maximal slope (MS), time to enhancement (TTE), and area under the curve (AUC) were statistically examined using the Mann-Whitney test and receiver operator characteristic (ROC) curve analysis. Results: On ultrafast MRI, breast cancer lesions enhanced earlier than BPE (p < 0.0001), enabling breast cancer visualization freed from lactation BPE. A higher CNR was found for ultrafast acquisitions vs. conventional DCE (p < 0.05). Significant differences in AUC, MS, and TTE values were found between the tumor and BPE (p < 0.05), with ROC-derived AUC of 0.86 ± 0.06, 0.82 ± 0.07, and 0.68 ± 0.08, respectively. The BPE grades of the lactating PABC patients were reduced as compared with the healthy lactating controls (p < 0.005). Conclusion: Ultrafast DCE MRI allows BPE-free visualization of lesions, improved tumor conspicuity, and kinetic quantification of breast cancer during lactation. Implementation of this method may assist in the utilization of breast MRI for lactating patients. Clinical relevance: The ultrafast sequence appears to be superior to conventional DCE MRI in the challenging evaluation of the lactating breast. Thus, supporting its possible utilization in the setting of high-risk screening during lactation and the diagnostic workup of PABC. Key points: • Differences in the enhancement slope of cancer relative to BPE allowed the optimal visualization of PABC lesions on mid-acquisitions of ultrafast DCE, in which the tumor enhanced prior to the background parenchyma. • The conspicuity of PABC lesions on top of the lactation-related BPE was increased using an ultrafast sequence as compared with conventional DCE MRI. • Ultrafast-derived maps provided further characterization and parametric contrast between PABC lesions and lactation-related BPE.

MRI can accurately diagnose breast cancer during lactation

Ultrafast DCE-MRI for discriminating pregnancy-associated breast cancer lesions from lactation related background parenchymal enhancement

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI

MRI of the Lactating Breast

Diagnostic Evaluations of Ultrasound and Magnetic Resonance Imaging in Mammary Duct Ectasia and Breast Cancer

Diagnosis of Suspicious Breast Lesions Using an Empirical Mathematical Model for Dynamic Contrast-Enhanced MRI

The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast

Accuracy of Combined Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging for Breast Cancer Detection: a Meta-Analysis.

The value of DCE- MRI of the breast as a diagnostic tool in assessing amorphous calcifications in screening mammography

Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort

A deep learning model based on dynamic contrast-enhanced magnetic resonance imaging enables accurate prediction of benign and malignant breast lessons

Evaluation of the Role of Dynamic Contrast-Enhanced Mr Imaging for Patients with Bi-Rads 3-4 Microcalcifications

The quantitative analysis of MR dynamic contrast-enhancement in benign and malignant breast nodules

Correlation Between Pharmacokinetic Analysis of DCE-MRI and Breast Image Reporting and Data System (BIRADS) Classification.

Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI

Possibilities of MRI in the differential diagnosis of non-lactative mastitis and cancer

Diffusion-tensor Imaging As an Adjunct to Dynamic Contrast-Enhanced MRI for Improved Accuracy of Differential Diagnosis Between Breast Ductal Carcinoma in Situ and Invasive Breast Carcinoma

Diagnosis of Breast Cancer Using Radiomics Models Built Based on Dynamic Contrast Enhanced MRI Combined With Mammography

The diagnosis of dynamic enhanced MRI for breast carcinoma

MR Imaging Evalution of Ductal Carcinoma in Situ and Ductal Carcinoma in Situ with Small Invasive Foci of Breast

Pilot study: A simple CAD-based tool to detect breast cancer on MRI of the breast